Feedback / Questions
prexasertib (ACR-368) - Acrivon Therap
ACR-2316 - Acrivon Therap
https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-announces-positive-acr-368-phase-2b
Jan 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next